alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › biomarkers-profile

biomarkers-profile

5 studies tagged biomarkers-profile, dated 2015-01-01 to 2025-08-06. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles 2025-08-06
  2. Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease 2023-07-31
  3. Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile 2021-07-27

Studies

5 studies carry this tag.

Date range

2015 to 2025

Top journals

  • Alzheimer's research & therapy 1
  • European journal of nuclear medicine and molecular imaging 1
  • JAMA neurology 1
  • Journal of Alzheimer's disease : JAD 1
  • Neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. European journal of nuclear medicine and molecular imaging 2025-08-06 Biomarkers

    Plasma pTau217 is effective for predicting A/T biomarker profile and cognitive decline, though further study is needed to better explain its association with Aβ and tau PET staging.

  2. Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. JAMA neurology 2023-07-31 Biomarkers

    Longitudinally, no significant differences in rates of worsening were observed between A-T+ and A-T- profiles for cognition or imaging biomarkers.

  3. Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Alzheimer's research & therapy 2021-07-27 Biomarkers

    There are biologically meaningful Aβ-downstream effects in individuals with a low burden of Aβ pathology, while structural and functional changes are still subtle or absent.

  4. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2016-08-17 Biomarkers

    These findings suggest that a simple blood-based signature not only provides estimates of NAB but also predicts cognitive decline and disease progression, identifying individuals at risk of progressing toward AD at the prodromal and preclinical stages.

  5. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2015-01-01 Biomarkers

    The diagnosis of idiopathic normal pressure hydrocephalus (iNPH) is sometimes complicated by concomitant Alzheimer's disease (AD) pathology.

All topic tags with their study counts